drug
(ceftolozane sulfate + tazobactam sodium)
Marketedupdated 3mo agoby $MRK Merck & Co., Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 15, 2028
~1.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Aug 14, 2035formulationUS 10125149
- Sep 9, 2034method-of-use (U-2610)US 10376496
- Sep 9, 2034method-of-use (U-3090)US 10933053
- May 28, 2034compositionUS 8906898
- Mar 14, 2034method-of-use (U-3360)US 10420841
- Mar 14, 2034method-of-use (U-3336)US 11278622
- Mar 14, 2034method-of-use (U-3360)US 8968753
- Mar 14, 2034formulationUS 9320740
- Mar 14, 2034formulationUS 9872906
- Sep 7, 2032method-of-use (U-2565)US 10028963
- Sep 7, 2032method-of-use (U-2566)US 9724353
- May 15, 2028compositionUS 71292321.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that